Suppr超能文献

体外膜肺氧合支持婴幼儿和青少年暴发性心肌炎患者:体外生命支持组织登记的回顾。

Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry.

机构信息

Department of Cardiology, Children's Hospital Boston, Boston, MA, USA.

出版信息

Crit Care Med. 2010 Feb;38(2):382-7. doi: 10.1097/CCM.0b013e3181bc8293.

Abstract

OBJECTIVE

To describe survival outcomes for pediatric patients supported with extracorporeal membrane oxygenation for severe myocarditis and identify risk factors for in-hospital mortality.

DESIGN

Retrospective review of Extracorporeal Life Support Organization registry database.

SETTING

Data reported to Extracorporeal Life Support Organization from 116 extracorporeal membrane oxygenation centers.

PATIENTS

Patients < or = 18 yrs of age supported with extracorporeal membrane oxygenation for myocarditis during 1995 to 2006.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Of 19,348 reported pediatric extracorporeal membrane oxygenation uses from 1995 to 2006, 260 runs were for 255 patients with a diagnosis of myocarditis (1.3%). Survival to hospital discharge was 61%. Seven patients (3%) underwent heart transplantation and six patients survived to discharge. Of 100 patients not surviving to hospital discharge, extracorporeal membrane oxygenation support was withdrawn in 70 (70%) with multiple organ failure as the indication in 58 (83%) patients. In a multivariable model, female gender (adjusted odds ratio, 2.3, 95% confidence interval, 1.3-4.2), arrhythmia on extracorporeal membrane oxygenation (adjusted odds ratio, 2.7, 95% confidence interval, 1.5-5.1), and renal failure requiring dialysis (adjusted odds ratio, 5.1, 95% confidence interval, 2.3-11.4) were associated with increased odds of in-hospital mortality.

CONCLUSION

Extracorporeal membrane oxygenation is a valuable tool to rescue children with severe cardiorespiratory compromise related to myocarditis. Female gender, arrhythmia on extracorporeal membrane oxygenation, and need for dialysis during extracorporeal membrane oxygenation were associated with increased mortality.

摘要

目的

描述体外膜氧合支持下严重心肌炎患儿的生存结果,并确定院内死亡率的危险因素。

设计

对体外生命支持组织登记数据库进行回顾性分析。

设置

从 1995 年至 2006 年,向体外生命支持组织报告的 116 个体外膜氧合中心的数据。

患者

1995 年至 2006 年期间,18 岁以下因心肌炎接受体外膜氧合支持的患者。

干预措施

无。

测量和主要结果

在 1995 年至 2006 年期间报告的 19348 例儿科体外膜氧合应用中,有 260 例用于 255 例心肌炎诊断患者(1.3%)。存活至出院的生存率为 61%。7 例(3%)患者接受了心脏移植,6 例患者存活至出院。在 100 例未存活至出院的患者中,70 例(70%)因多器官衰竭而撤除外周膜氧合,其中 58 例(83%)患者的指征为多器官衰竭。在多变量模型中,女性(调整比值比,2.3,95%置信区间,1.3-4.2)、体外膜氧合时心律失常(调整比值比,2.7,95%置信区间,1.5-5.1)和需要透析的肾衰竭(调整比值比,5.1,95%置信区间,2.3-11.4)与院内死亡率增加相关。

结论

体外膜氧合是抢救因心肌炎导致严重心肺功能衰竭的儿童的有效工具。女性、体外膜氧合时的心律失常和体外膜氧合期间需要透析与死亡率增加相关。

相似文献

引用本文的文献

2
How to behave with paediatric myocarditis: imaging methods and clinical considerations.小儿心肌炎的处理方式:影像学方法与临床考量
Eur Heart J Imaging Methods Pract. 2025 Apr 4;3(1):qyaf025. doi: 10.1093/ehjimp/qyaf025. eCollection 2025 Jan.
8
Implication of microRNA as a potential biomarker of myocarditis.微小RNA作为心肌炎潜在生物标志物的意义。
Clin Exp Pediatr. 2022 May;65(5):230-238. doi: 10.3345/cep.2021.01802. Epub 2022 Mar 2.

本文引用的文献

6
Technology insight: Use of ventricular assist devices in children.技术洞察:儿童心室辅助装置的应用
Nat Clin Pract Cardiovasc Med. 2006 Jul;3(7):377-86. doi: 10.1038/ncpcardio0575.
8
Myocarditis: current trends in diagnosis and treatment.心肌炎:诊断与治疗的当前趋势
Circulation. 2006 Feb 14;113(6):876-90. doi: 10.1161/CIRCULATIONAHA.105.584532.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验